Key Highlights
- Jean-Claude “JC” Kyrillos appointed as Executive Vice President and COO, effective June 21, 2024.
- Brings over 20 years of global executive leadership in medical device, digital health, and healthcare management.
- Previously held key roles at Envista Holdings, Qualcomm Life, Becton Dickinson, and ResMed Inc.
Source: Business Wire
Notable Quotes
- “JC brings deep experience in healthcare and a great balance of technical, operational, and leadership skills from multiple roles in large and small medical technology companies. JC shares our strong commitment to helping improve lives, and I look forward to working together as we advance our pipeline to bring more solutions to people living with diabetes.” — John Sheridan, President and CEO at Tandem Diabetes Care
- “I was drawn to Tandem’s dedication to making a positive impact in the diabetes community, while addressing growing demand for smaller, more advanced insulin delivery technologies. I look forward to adding my experience to the talented team already in place and helping deliver on Tandem’s mission through the expansion of our global operations while delivering profitable growth.” — Jean-Claude “JC” Kyrillos, Executive Vice President and Chief Operating Officer at Tandem Diabetes Care
SoHC's Take
The appointment of Jean-Claude Kyrillos as Executive Vice President and Chief Operating Officer at Tandem Diabetes Care is a strategic move that aligns with the company’s mission to advance its global operations and deliver profitable growth. Kyrillos’ extensive experience in leading roles across major medical technology companies, such as Envista Holdings, Qualcomm Life, Becton Dickinson, and ResMed Inc., positions him as an ideal leader to drive Tandem’s ambitious growth plans. His proven track record in digital health and medical devices will be instrumental in expanding Tandem’s innovative insulin delivery technologies, further enhancing the company’s impact on the diabetes community. This leadership change underscores Tandem’s commitment to operational excellence and innovation in diabetes care solutions.
